Since 2024 began, Nvidia has surged by 11.3%, according to data provided by S&P Global Market Intelligence. New uses for NVDA chips: at the J.P. Morgan conference, Nvidia revealed how computer aided drug discovery will accelerate progress similar to how computer aided design (CAD) did for chip design. NVDA's BioNeMo AI platform for drug discovery has already been deployed by an Amgen subsidiary for its genomics foundation molecular models. That, along with new gaming, generative AI, and robotics innovations revealed at the CES--we're doing fine. Go Long. $NVIDIA Corp(NVDA)$
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
